Pharma and Biotech
By Benjamin Chiou
Date: Wednesday 02 Oct 2024
(Sharecast News) - Shares in Hemogenyx Pharmaceuticals jumped on Wednesday after the clinical-stage biopharmaceutical group announced another investment from Prevail Partners via a share subscription at a significant premium to the current market value.
By Benjamin Chiou
Date: Monday 18 Sep 2023
(Sharecast News) - Shares in biopharma group Hemogenyx surged on Monday after the company received a $0.83m investment from Prevail Partners as it continues to work on its planned clinical trial for leukaemia treatment.
By Josh White
Date: Wednesday 23 Oct 2019
(Sharecast News) - Biopharmaceutical group Hemogenyx Pharmaceuticals announced on Wednesday that its wholly-owned subsidiary Immugenyx has entered into a research agreement with a global pharmaceutical company.
Currency | UK Pounds |
Share Price | 339.50p |
Change Today | -8.00p |
% Change | -2.30 % |
52 Week High | 1,582.00 |
52 Week Low | 320.00 |
Volume | 7,700 |
Shares Issued | 3.60m |
Market Cap | £12.24m |
RiskGrade | 340 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:47 | 2 @ 344.00p |
16:20 | 3 @ 340.00p |
15:47 | 2 @ 344.00p |
15:30 | 400 @ 335.60p |
14:11 | 92 @ 335.50p |
You are here: research